Author: Alison Mohr Date: 24 February 2012 Journal article
Bioethics, law and the regulation of biotechnologies in the European Union: the case of umbilical cord stem cell banking
- Start date: 12 February 2007
- End date: 11 February 2008
This project aims to provide an analysis of the influence of non-statutory expert bioethics bodies on the formulation of law, policy and regulation of biotechnologies in the European Union (EU). Negotiations about the ethics of biotechnologies have the potential to impact on formal national law and regulatory regimes. These dynamics will be explored via a case study of a recent controversy about the ethics of commercial umbilical cord stem cell banking.
The activities of commercial ‘cord blood banks’ have been of significant concern in Europe, where the issue was first raised in the European Parliament by 2001, and discussed by the European Group on Ethics. These companies advertise the possibility of banking of cord blood in case it may be of value in the future to children or their siblings. The speculative nature of claims of future value, and the threat to the traditional basis of public blood banking are amongst the objections raised by these bodies, which have sought to influence law and regulation of these activities.
Methods deployed include a review of policy and academic literature, scrutiny of EU policy documents, interviews with EU bioethics advisors and other relevant actors, and the tracking of relevant legislative proposals.
- Outputs (6)
Author: H. Busby Date: 26 January 2010 Journal article
Author: Helen Busby Date: 08 May 2008 Full research report
Author: Helen Busby Date: 08 May 2008 Research summary
Author: Tamara Hervey Date: 17 April 2008 Conference paper/presentation
Author: Alison Mohr Date: 17 April 2008 Conference paper/presentation